Overview
VCYT market data
Price History
VCYT price chart · 1M
- O
- 44.31
- H
- 45.49
- L
- 44.31
- C
- 45.28
- Vol
- 83,860.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $44.31
- Previous Close
- $44.28
- Day High
- $45.49
- Day Low
- $44.31
- 52 Week High
- $60.77
- 52 Week Low
- $31.17
- 7 Day Return
- +8.46%
- 30 Day Return
- -18.56%
- 90 Day Return
- -2.33%
- 1 Year Return
- +42.48%
- Daily Notional Volume
- $3.8M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 29.24 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.82 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.98 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 20.4% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $28.25 – $60.91 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $3.3B · P/B 2.54 · P/S 5.96.
Company News
Top 3 Health Care Stocks That Could Blast Off This MonthBenzinga · Aug 19, 2026, 10:30 AM
Piper Sandler Maintains Overweight on Veracyte, Lowers Price Target to $54Benzinga · Aug 4, 2026, 2:41 PM
Stephens & Co. Maintains Overweight on Veracyte, Lowers Price Target to $55Benzinga · Aug 4, 2026, 1:07 PM
Morgan Stanley Maintains Underweight on Veracyte, Lowers Price Target to $44Benzinga · Aug 4, 2026, 12:42 PM
Canaccord Genuity Maintains Hold on Veracyte, Lowers Price Target to $50Benzinga · Aug 3, 2026, 9:29 PM
Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market SessionBenzinga · Jul 31, 2026, 12:02 PM
Needham Maintains Buy on Veracyte, Raises Price Target to $69Benzinga · Jul 31, 2026, 9:45 AM
8-K filing — VERACYTE, INC. (VCYT)SEC EDGAR · Jul 30, 2026, 8:18 PM
Veracyte Raises FY2026 Sales Guidance from $582.000M-$592.000M to $590.000M-$596.000M vs $586.445M EstBenzinga · Jul 30, 2026, 8:06 PM
Veracyte Q2 Adj. EPS $0.54 Beats $0.24 Estimate, Sales $150.321M Beat $144.554M EstimateBenzinga · Jul 30, 2026, 8:05 PM